Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

AIMS: To evaluate apixaban single dose safety, tolerability, pharmacokinetics and pharmacodynamics and assess the effect of food on apixaban pharmacokinetics. METHODS: A double-blind, placebo-controlled, single ascending-dose, first-in-human study assessed apixaban safety, pharmacokinetics and pharm...

Descripción completa

Detalles Bibliográficos
Autores principales: Frost, Charles, Wang, Jessie, Nepal, Sunil, Schuster, Alan, Barrett, Yu Chen, Mosqueda-Garcia, Rogelio, Reeves, Richard A, LaCreta, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Science Inc 2013
Materias:
Pharmacokinetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558798/
https://www.ncbi.nlm.nih.gov/pubmed/22759198
http://dx.doi.org/10.1111/j.1365-2125.2012.04369.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558798/
https://www.ncbi.nlm.nih.gov/pubmed/22759198
http://dx.doi.org/10.1111/j.1365-2125.2012.04369.x

Ejemplares similares